QUOTE AND NEWS
Business Standard  3 hrs ago  Comment 
Though domestic sales are robust, concerns at Caraco and Taro remain.
New Straits Times  Feb 1  Comment 
KUCHING: Dental practitioners will soon be required to acquire "continuous professional development" (CPD) credit points before they can renew their annual practising licences.
New Straits Times  Jan 31  Comment 
KUCHING, Sun: Dental practitioners will soon be required to acquire "continuous professional development" (CPD) credit points before they could renew their annual practising licences.
StreetInsider.com  Jan 28  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Caraco+Pharma+Ltd.+%28CPD%29+Posts+Q3+Loss+of+%240.08%2C+Wider+than+Estimates/5286126.html for the full story.
PR Newswire  Jan 28  Comment 
DETROIT, Jan. 28 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) generated net sales of $52.0 million and $178.4 million for the third quarter and first nine months of Fiscal 2010, respectively, compared to $55.7
Motley Fool  Dec 9  Comment 
Yesterday's market is today's moneymaking road map.
Motley Fool  Dec 4  Comment 
Maybe what glitters really is gold.
PR Newswire  Nov 18  Comment 
DETROIT, Nov. 18 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) has launched Nicardipine Hydrochloride Injection immediately following Sun Pharma's final approval from the US Food and Drug Administration (FDA).
FiercePharma  Nov 3  Comment 
What to do when the FDA has cracked down on your U.S. drug production? Perhaps move manufacturing to India. That's what Caraco Pharmaceuticals is considering as it works to resolve the agency's concerns about a U.S. plant, according to the...
The Economic Times  Nov 1  Comment 
Sun Pharmaceutical Industries' US-based subsidiary Caraco, which is facing a Food and Drug Administration ban on manufacturing, is looking at shifting production of some of the drugs to India.



Thank you for your suggestion


 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki